Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suki Albers

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Life (Basel, Switzerland)|January 23, 2016
Exploiting tRNAs to Boost VirulenceSuki Albers, Andreas Czech
Pharmacology & Therapeutics|August 24, 2025
Suppressor tRNAs as personalized therapy for nonsense mutation-associated pathologiesZoya Ignatova, Suki Albers
International Journal of Molecular Sciences|May 15, 2019
Computational Aminoacyl-tRNA Synthetase Library Design for Photocaged TyrosineTobias Baumann, Matthias Hauf, Florian Richter, et al.
Nature Communications|April 5, 2024
Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutationsNikhil Bharti, Leonardo Santos, Marcos Davyt, et al.
Nature Communications|June 23, 2021
Repurposing tRNAs for nonsense suppressionSuki Albers, Bertrand Beckert, Marco C Matthies, et al.
Nature|May 31, 2023
Engineered tRNAs suppress nonsense mutations in cells and in vivoSuki Albers, Elizabeth C Allen, Nikhil Bharti, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Life (Basel, Switzerland)|January 23, 2016
Exploiting tRNAs to Boost VirulenceSuki Albers, Andreas Czech
Pharmacology & Therapeutics|August 24, 2025
Suppressor tRNAs as personalized therapy for nonsense mutation-associated pathologiesZoya Ignatova, Suki Albers
International Journal of Molecular Sciences|May 15, 2019
Computational Aminoacyl-tRNA Synthetase Library Design for Photocaged TyrosineTobias Baumann, Matthias Hauf, Florian Richter, et al.
Nature Communications|April 5, 2024
Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutationsNikhil Bharti, Leonardo Santos, Marcos Davyt, et al.
Nature Communications|June 23, 2021
Repurposing tRNAs for nonsense suppressionSuki Albers, Bertrand Beckert, Marco C Matthies, et al.
Nature|May 31, 2023
Engineered tRNAs suppress nonsense mutations in cells and in vivoSuki Albers, Elizabeth C Allen, Nikhil Bharti, et al.
Pageof 1